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EDITORIALS
Enlightening Ways to Relax Airway Smooth Muscle: Opsins
GPCRs (G protein–coupled receptors) are the largest gene family in
the human genome and are the direct or indirect targets of most
prescribed drugs. In obstructive lung diseases such as asthma and
chronic obstructive pulmonary disease, two GPCRs have been
historically targeted for therapeutic control of the exaggerated
contraction of airway smooth muscle (ASM) and the associated
resistance to breathing: the b2AR (b-2 adrenoceptor) and the m3
mAChR (m3 muscarinic acetylcholine receptor) (1). The m3
mAChR mediates the procontractile effects of acetylcholine on ASM,
which are enhanced in asthma by inflammatory actions in the
airway. The b2AR mediates prorelaxant signaling in ASM, effectively
counteracting the procontractile signaling of the m3 mAChR.
Other well-known GPCRs with procontractile and prorelaxant
signaling capabilities have been identified and characterized in ASM,
making them putative therapeutic targets (reviewed in References
1–3). Recently, a curious collection of GPCRs, including orphan
receptors, as well as other GPCRs known better for their actions in
tissues and cells outside the lung, have also been found in ASM.
These include members of the bitter taste receptor family (4),
odorant receptors (5), calcium sensing receptors (6), and proton-
sensing receptors (7). Each has been shown to be expressed, signal,
and, when activated, either contract or relax ASM cells and airways
ex vivo or promote or reverse airway resistance in vivo. In this issue
of the Journal, Wu and colleagues (pp. 59–68) advance the
photoreceptive GPCR OPN3 (Opsin 3) receptor as a novel ASM
GPCR capable of regulating the ASM contractile state (8).
OPN3 is member of the Opsin family of GPCRs more
commonly known for their role in vision. OPN2 (rhodopsin)
is a well-characterized GPCR expressed in the retina, mediating
vision signal transduction in response to photons. Primordial opsins,
found in single-cell organisms, react with external light in the
visible spectrum and modulate intracellular processes during times
of dark and light. Although primitive opsin receptors are mostly
ion channels and ion pumps, vertebrate opsins rely on G protein
second messengers to transduce cellular signals (Figure 1). As
evolution progressed from single-cell organisms to vertebrates,
regions of specialized cells retained a high sensitivity to light
(i.e., the eye). However, the expression of opsins in nonvisual tissues
was retained despite no known direct connection to the central
nervous system. Opsin 3 in particular is expressed and functional
in an array of different organs (9–14). But what is the use of
light-sensitive proteins in areas that have dramatically less light,
if any light at all? Perhaps evolution retained these primordial
adaptations of our predecessors, such that somatic opsins
modulate peripheral functions with light through circadian
rhythm (9).
OPN3 and other extraocular opsins respond to specific
wavelengths of light in the presence of a chromophore. In their
2019 paper, Yim and colleagues first noted the expression of
OPN3 in both mouse and human ASM cells, and demonstrated
photorelaxation of ex vivo contracted airways from both human





















Figure 1. Putative Opsin (OPN)-mediated signaling promotes relaxation of airway smooth muscle (ASM). Light, synthetic, or endogenous agonist(s)
activate the OPN receptor, which initiates a signaling cascade causing activation of AC via Gas leading to an increase in cAMP, followed by activation
of PKA, which can promote downstream pathways of ASM relaxation. AC=adenylyl cyclase; HOOC=carboxyl group; K1=potassium; P=phosphate;
PKA=protein kinase A.
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Moreover, this relaxation could be enhanced by the addition
of the OPN chromophore 9 cisretinal, whereas pharmacological
blockade of the large conductance calcium-activated potassium
channel (BK) significantly attenuated the relaxation. In the current
study, Wu and colleagues demonstrate that Opn3 gene ablation
significantly reduces the relaxation of contracted tracheal rings by
blue light.
The effect of BK channel inhibition notwithstanding, the
prorelaxant signaling and mechanisms mediating blue
light–induced photorelaxation of ASM remained largely
undetermined. Whereas the signaling mechanisms by photon-
activated rhodopsin enabling vision have been exhaustively
delineated, the signaling mechanisms by which extraocular opsin
regulates cellular function are poorly understood. Wu and
colleagues undertook a systematic analysis of OPN3 downstream
signaling elements in ASM, with the goal of linking these
elements to the regulation of ASM contraction. In human ASM
cells, Gas was shown to coimmunoprecipitate with OPN3 and
could also be visualized in close proximity to OPN3 in cellular
fluorescence assays. Consistent with these observations, blue
light was able to induce cAMP accumulation in tracheal ring
preparations. Of note, BK channel conductance is known to
be enhanced by the (cAMP-activated) cAMP-dependent PKA
(protein kinase A).
The critical role of OPN3/Gas/cAMP/PKA signaling in OPN3-
mediated photorelaxation was confirmed by demonstrating that the
pharmacological inhibition of PKA with Rp-cAMPS effectively
reversed the relaxation of contracted tracheal rings by blue light.
Collectively, these findings suggest that OPN3 uses canonical
GPCR signaling to PKA to relax ASM, similar to the mechanisms of
relaxation effected by b2AR agonism, albeit with a seemingly greater
dependence on BK channels as PKA effectors. In addition, the
present study reveals that OPN3 appears subject to similar
mechanisms of desensitization known to affect the b2AR. GRK2
(GPCR kinase 2), which phosphorylates the b2AR (and other
GPCRs) to diminish its coupling to G protein, is shown to colocalize
with OPN3, and to coimmunoprecipitate with OPN3 as well.
Consistent with GRK2-mediated desensitization, inhibition of GRK2
also significantly increases the relaxant effect of blue light.
Finally, the retention of some measure of photorelaxation
in tracheal rings from OPN3 null mice suggests the possibility
of other photoreceptive opsins in ASM. Indeed, the original
description of opsin receptors in ASM by this group (12) described
the expression of OPN4 in murine ASM as well.
Owing to the low penetration of blue wavelengths of light
through tissues, it seems likely that ligands that activate OPN3 in the
absence of light will be the only practical way of harnessing prorelaxant
signaling capabilities of OPN3 in ASM. An obvious teleological
assumption is “if these receptors are in the airway, there must
be an endogenous ligand that is not light.” Whether or not an
endogenous ligand can be found, the potential exists for synthetic
ligand development of OPN3 agonists, based on structure–activity
relationship studies, receptor modeling, and other creative strategies,
such as those recently used to discover agonists for the proton-sensing
receptor GPR68 (16), whose cognate ligand is believed to be the
proton.
And although we can likely bank on the increasing capabilities
of synthetic chemistry to deliver a small-molecule OPN3 agonist,
it should be noted that (therapeutic) photorelaxation of ASM is
still on the table. Wu and colleagues present data that ASM
transduced to express an isoform of opsin sensitive to more
tissue-penetrant wavelengths of light (OPN1LW), increased cyclic
AMP in response to longer wavelengths of light. This raises the
question as to whether ASM and other peripheral tissues expressed
isoforms of opsins that indeed respond to tissue-penetrating
wavelengths of light.
These findings describe yet another family of receptors that are
expressed in ASM that were previously thought to be only expressed
in sensory tissues, joining the families of odorant and olfactory
receptors in this regard. Future research will need to identify
endogenous or synthetic ligands, and sensitizing chromophores,
of the opsin family of receptors to fully realize their prorelaxant
potential in ASM. n
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